Stryker will announce Q2 2025 financial results on July 31, 2025, with a subsequent webcast at 4:30 p.m. ET.
Quiver AI Summary
Stryker Corporation will release its financial results for the second quarter of fiscal year 2025 on July 31, 2025, with a press release set to be issued at approximately 4:05 p.m. ET. This release will detail the company's performance for the quarter ending June 30, 2025. Following the release, Stryker will host a webcast at 4:30 p.m. ET to discuss the results, which will be accessible on their website, along with an archived version available two hours post-event. Stryker, a leader in medical technologies, focuses on improving healthcare outcomes through innovative products and services, impacting over 150 million patients globally each year. For investor and media inquiries, specific contacts have been provided.
Potential Positives
- Stryker will report its second quarter financial results, providing stakeholders with key insights into its fiscal performance.
- The company will host a webcast to discuss the financial results, enhancing transparency and engagement with investors.
- As a global leader in medical technologies, Stryker's focus on innovative products and services positions it well in a competitive industry.
- The announcement underscores Stryker's commitment to improving healthcare outcomes, impacting more than 150 million patients annually.
Potential Negatives
- None
FAQ
When will Stryker report its financial results for Q2 2025?
Stryker will report its financial results for the second quarter on July 31, 2025.
What time will the Q2 2025 press release be issued?
The press release will be issued at approximately 4:05 p.m. ET on July 31, 2025.
How can I access the Q2 2025 webcast?
The webcast will be accessible at Stryker - Events & Presentations starting at 4:30 p.m. ET on July 31, 2025.
Will there be an archive of the Q2 2025 webcast?
Yes, an archive of the webcast will be available on the company's website two hours after the live call ends.
Who can I contact for investor inquiries at Stryker?
For investor inquiries, contact Jason Beach at 269-385-2600 or [email protected].
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SYK Congressional Stock Trading
Members of Congress have traded $SYK stock 10 times in the past 6 months. Of those trades, 4 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $SYK stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 04/17 and 2 sales worth up to $200,000 on 05/12, 03/13.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/08.
- REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 3 purchases worth up to $45,000 on 04/07, 01/15 and 0 sales.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.
- REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $50,000 on 02/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$SYK Insider Trading Activity
$SYK insiders have traded $SYK stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $SYK stock by insiders over the last 6 months:
- RONDA E STRYKER has made 0 purchases and 12 sales selling 401,392 shares for an estimated $154,384,916.
- ALLAN C. GOLSTON sold 2,458 shares for an estimated $941,586
- WILLIAM E JR BERRY (VP, Chief Accounting Officer) sold 1,241 shares for an estimated $482,202
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SYK Hedge Fund Activity
We have seen 1,086 institutional investors add shares of $SYK stock to their portfolio, and 894 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP removed 1,981,824 shares (-23.7%) from their portfolio in Q1 2025, for an estimated $737,733,984
- JPMORGAN CHASE & CO added 1,808,077 shares (+16.7%) to their portfolio in Q1 2025, for an estimated $673,056,663
- BANK OF AMERICA CORP /DE/ added 1,040,407 shares (+35.0%) to their portfolio in Q1 2025, for an estimated $387,291,505
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,021,496 shares (+9.2%) to their portfolio in Q1 2025, for an estimated $380,251,886
- GREENLEAF TRUST removed 628,360 shares (-3.5%) from their portfolio in Q1 2025, for an estimated $233,907,010
- PROFICIO CAPITAL PARTNERS LLC removed 594,363 shares (-99.7%) from their portfolio in Q1 2025, for an estimated $221,251,626
- MORGAN STANLEY added 559,172 shares (+10.1%) to their portfolio in Q1 2025, for an estimated $208,151,777
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SYK Analyst Ratings
Wall Street analysts have issued reports on $SYK in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 05/22/2025
- Bernstein issued a "Outperform" rating on 05/05/2025
- BTIG issued a "Buy" rating on 04/14/2025
To track analyst ratings and price targets for $SYK, check out Quiver Quantitative's $SYK forecast page.
$SYK Price Targets
Multiple analysts have issued price targets for $SYK recently. We have seen 4 analysts offer price targets for $SYK in the last 6 months, with a median target of $436.0.
Here are some recent targets:
- Lee Hambright from Bernstein set a target price of $450.0 on 05/05/2025
- Ryan Zimmerman from BTIG set a target price of $403.0 on 04/14/2025
- An analyst from Goldman Sachs set a target price of $422.0 on 03/04/2025
- David Toung from Argus Research set a target price of $450.0 on 02/03/2025
Full Release
Portage, Michigan, July 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its second quarter of fiscal year 2025 on Thursday, July 31, 2025. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s second quarter that ended June 30, 2025.
Stryker will host a webcast at 4:30 p.m. ET on Thursday, July 31, 2025, to discuss its second quarter 2025 results. The webcast can be accessed at Stryker - Events & Presentations . An archive of the webcast will also be available on the company's website two hours after the live call ends.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries:
Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or
[email protected]
For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or
[email protected]